Tobacco smoking and long-lasting symptoms from the bowel and the anal-sphincter region after radiotherapy for prostate cancer

Radiotherapy and Oncology

Volumn 101, Issue 3, 2011, Pages 495-501

  Alsadius, David ^b   Hedelin, Maria ^a,b   Johansson, Karl Axel ^b   Pettersson, Niclas ^b   Wilderäng, Ulrica ^b   Lundstedt, Dan ^b   Steineck, Gunnar ^a,b  

^a Clinical Cancer Epidemiology   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Bowel; Late toxicity; Prostate cancer; Radiotherapy; Tobacco smoking

Indexed keywords

AGED; ANUS SPHINCTER; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVOR; CONTROLLED STUDY; DEFECATION URGENCY; DEMOGRAPHY; DIARRHEA; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; INTESTINE; INTESTINE MOTILITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; QUESTIONNAIRE; SMOKING;

AGED; ANAL CANAL; HUMANS; INTESTINES; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; SMOKING;

EID: 81855222034     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2011.06.010     Document Type: Article

References (33)

1. J.A. Ambrose, and R.S. Barua The pathophysiology of cigarette smoking and cardiovascular disease: an update J Am Coll Cardiol 43 2004 1731 1737
2. S.M. Bentzen Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology Nat Rev Cancer 6 2006 702 713
3. P.J. Eifel, A. Jhingran, D.C. Bodurka, C. Levenback, and H. Thames Correlation of smoking history and other patient characteristics with major complications of pelvic radiation therapy for cervical cancer J Clin Oncol 20 2002 3651 3657
4. H. Kucera, H. Enzelsberger, W. Eppel, and K. Weghaupt The influence of nicotine abuse and diabetes mellitus on the results of primary irradiation in the treatment of carcinoma of the cervix Cancer 60 1987 1 4
5. J.C. van der Voet, R.B. Keus, A.A. Hart, F.J. Hilgers, and H. Bartelink The impact of treatment time and smoking on local control and complications in T1 glottic cancer Int J Radiat Oncol Biol Phys 42 1998 247 255
6. A. Widmark, O. Klepp, and A. Solberg Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial Lancet 373 2009 301 308
7. P. Fransson, J.A. Lund, and J.E. Damber Quality of life in patients with locally advanced prostate cancer given endocrine treatment with or without radiotherapy: 4-year follow-up of SPCG-7/SFUO-3, an open-label, randomised, phase III trial Lancet Oncol 10 2009 370 380
8. A.C. Waldenström, D. Alsadius, and N. Pettersson Variation in position and volume of organs at risk in the small pelvis Acta Oncol 49 2010 491 499
9. K. Bergmark, E. vall-Lundqvist, P.W. Dickman, L. Henningsohn, and G. Steineck Vaginal changes and sexuality in women with a history of cervical cancer N Engl J Med 340 1999 1383 1389
10. U. Kreicbergs, U. Valdimarsdóttir, E. Onelöv, J.I. Henter, and G. Steineck Talking about death with children who have severe malignant disease N Engl J Med 351 2004 1175 1186
11. G. Steineck, K. Bergmark, L. Henningsohn, M. al-Abany, P.W. Dickman, and A. Helgason Symptom documentation in cancer survivors as a basis for therapy modifications Acta Oncol 41 2002 244 252
12. U. Valdimarsdóttir, A.R. Helgason, C.J. Fürst, J. Adolfsson, and G. Steineck Need for and access to bereavement support after loss of a husband to urologic cancers: a nationwide follow-up of Swedish widows Scand J Urol Nephrol 39 2005 271 276
13. S.M. Bentzen, L.S. Constine, and J.O. Deasy Quantitative analyses of normal tissue effects in the clinic (QUANTEC): an introduction to the scientific issues Int J Radiat Oncol Biol Phys 76 2010 S3 S9
14. Al-Abany, A.R. Helgason, J. Adolfsson, and G. Steineck Reliability of assessment of urgency and other symptoms indicating anal sphincter, large bowel or urinary dysfunction Scand J Urol Nephrol 40 2006 397 408
15. G. Dunberger, H. Lind, and G. Steineck Self-reported symptoms of faecal incontinence among long-term gynaecological cancer survivors and population-based controls Eur J Cancer 46 2010 606 615
16. G. Fellin, C. Fiorino, and T. Rancati Clinical and dosimetric predictors of late rectal toxicity after conformal radiation for localized prostate cancer: Results of a large multicenter observational study Radiother Oncol 93 2009 197 202
17. V. Fonteyne, W. De Neve, G. Villeirs, C. De Wagter, and G. De Meerleer Late radiotherapy-induced lower intestinal toxicity (RILIT) of intensity-modulated radiotherapy for prostate cancer: The need for adapting toxicity scales and the appearance of the sigmoid colon as co-responsible organ for lower intestinal toxicity Radiother Oncol 84 2007 156 163
18. H. Geinitz, F.B. Zimmermann, and R. Thamm Late rectal symptoms and quality of life after conformal radiation therapy for prostate cancer Radiother Oncol 79 2006 341 347
19. G.M. Duchesne, S.G. Williams, R. Das, and K.H. Tai Patterns of toxicity following high-dose-rate brachytherapy boost for prostate cancer: Mature prospective phase I/II study results Radiother Oncol 84 2007 128 134
20. P.C. Koper, P. Jansen, and W. van Putten Gastro-intestinal and genito-urinary morbidity after 3D conformal radiotherapy of prostate cancer: observations of a randomized trial Radiother Oncol 73 2004 1 9
21. K. Odrazka, M. Dolezel, and J. Vanasek Time course of late rectal toxicity after radiation therapy for prostate cancer Prostate Cancer Prostatic Dis 13 2009 138 143
22. S.J. Frank, A. Jhingran, C. Levenback, and P.J. Eifel Definitive radiation therapy for squamous cell carcinoma of the vagina Int J Radiat Oncol Biol Phys 62 2005 138 147
23. S.T. Peeters, W.D. Heemsbergen, and P.C. Koper Dose-response in radiotherapy for localized prostate cancer:results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy J Clin Oncol 24 2006 1990 1996
24. M.J. Zelefsky, Z. Fuks, and M. Hunt High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients Int J Radiat Oncol Biol Phys 53 2002 1111 1116
25. L.F. Paszat, W.J. Mackillop, P.A. Groome, C. Boyd, K. Schulze, and E. Holowaty Mortality from myocardial infarction after adjuvant radiotherapy for breast cancer in the surveillance, epidemiology, and end-results cancer registries J Clin Oncol 16 1998 2625 2631
26. N.S. Russell, S. Hoving, and S. Heeneman Novel insights into pathological changes in muscular arteries of radiotherapy patients Radiother Oncol 92 2009 477 483
27. N.D. Carr, B.R. Pullen, P.S. Hasleton, and P.F. Schofield Microvascular studies in human radiation bowel disease Gut 25 1984 448 454
28. J.M. Michalski, H. Gay, A. Jackson, S.L. Tucker, and J.O. Deasy Radiation dose-volume effects in radiation-induced rectal injury Int J Radiat Oncol Biol Phys 76 2010 123 129
29. L.E. Chambless, G. Heiss, A.R. Folsom, W. Rosamond, M. Szklo, and R. Sharrett Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993 Am J Epidemiol 146 1997 483 494
30. G. Howard, L.E. Wagenknecht, and G.L. Burke Cigarette smoking and progression of atherosclerosis: The Atherosclerosis Risk in Communities (ARIC) Study JAMA 279 1998 119 124
31. C. Heeschen, J.J. Jang, and M. Weis Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis Nat Med 7 2001 833 839
32. G. Steineck, H. Hunt, and J. Adolfsson A hierarchical step-model for causation of bias-evaluating cancer treatment with epidemiological methods Acta Oncol 45 2006 421 429
33. Swedish National Institute of Public Health, tobacco report 2008.